Myriad Genetics Inc financial data

Symbol
MYGN on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
322 North 2200 West, Salt Lake City, Utah
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 159 % -33%
Quick Ratio 12.9 % -11.5%
Debt-to-equity 55.1 % +63.9%
Return On Equity -12.1 % -313%
Return On Assets -20.4 % -67.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.5M shares +11%
Common Stock, Shares, Outstanding 90.5M shares +11%
Entity Public Float 1.9B USD +29.5%
Common Stock, Value, Issued 900K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 89.9M shares +10.6%
Weighted Average Number of Shares Outstanding, Diluted 89.9M shares +10.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 774M USD +11.4%
Research and Development Expense 91.1M USD +5.08%
Costs and Expenses 1.01B USD +16.9%
Operating Income (Loss) -233M USD -39.4%
Nonoperating Income (Expense) -2.4M USD -700%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -236M USD -41.2%
Income Tax Expense (Benefit) -900K USD +95.6%
Net Income (Loss) Attributable to Parent -235M USD -60.5%
Earnings Per Share, Basic -2.8 USD/shares -55.6%
Earnings Per Share, Diluted -2.8 USD/shares -55.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 96.9M USD +80.8%
Marketable Securities, Current 7.4M USD -70.5%
Cash, Cash Equivalents, and Short-term Investments 141M USD -17%
Accounts Receivable, after Allowance for Credit Loss, Current 118M USD -0.84%
Inventory, Net 24.6M USD +12.8%
Assets, Current 290M USD +11%
Property, Plant and Equipment, Net 119M USD +23.1%
Operating Lease, Right-of-Use Asset 58.9M USD -45%
Intangible Assets, Net (Excluding Goodwill) 341M USD -7.72%
Goodwill 287M USD -0.04%
Other Assets, Noncurrent 14.9M USD -14.9%
Assets 1.11B USD -5.03%
Accounts Payable, Current 33.1M USD -9.32%
Employee-related Liabilities, Current 37.8M USD -3.33%
Accrued Liabilities, Current 99.2M USD +8.18%
Contract with Customer, Liability, Current 500K USD -16.7%
Liabilities, Current 146M USD +1.95%
Deferred Income Tax Liabilities, Net 2.7M USD -74.3%
Operating Lease, Liability, Noncurrent 94.3M USD -35.6%
Other Liabilities, Noncurrent 40.6M USD +253%
Liabilities 351M USD +4.91%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.2M USD +43.2%
Retained Earnings (Accumulated Deficit) -656M USD -55.7%
Stockholders' Equity Attributable to Parent 760M USD -9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 886M USD -8.47%
Liabilities and Equity 1.11B USD -5.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.6M USD +44%
Net Cash Provided by (Used in) Financing Activities -8.8M USD -79.6%
Net Cash Provided by (Used in) Investing Activities -7.1M USD -121%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 90.5M shares +11%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -35.3M USD -970%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 106M USD +67.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 200K USD
Deferred Tax Assets, Valuation Allowance 95M USD +124%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 195M USD +21.2%
Depreciation 15.3M USD -12.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -231M USD -58.5%
Lessee, Operating Lease, Liability, to be Paid 161M USD -13.2%
Property, Plant and Equipment, Gross 229M USD +9.98%
Operating Lease, Liability, Current 13.8M USD -8.61%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.9M USD -24.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.5M USD +11.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -4.3M USD +85.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47.6M USD +152%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.6M USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 77.1M USD +15.8%
Deferred Federal Income Tax Expense (Benefit) -51.8M USD -101%
Current Income Tax Expense (Benefit) 5.4M USD +184%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 48.1M USD +9.57%
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.7M USD -28.2%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 1.8M USD -5.26%
Current Federal Tax Expense (Benefit) 3.4M USD
Amortization of Intangible Assets 42.9M USD +3.13%
Deferred Tax Assets, Net of Valuation Allowance 100M USD -15.6%
Share-based Payment Arrangement, Expense 9.4M USD -6%
Deferred State and Local Income Tax Expense (Benefit) -5.2M USD -8.33%
Interest Expense 2.9M USD +3.57%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%